Mechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Summary Caloric restriction rapidly reverses type 2 diabetes (T2D) but the mechanism(s) of this reversal are poorly understood. Here we show that three days of a very low-calorie diet (VLCD, 1/4 their typical intake) lowered plasma glucose and insulin concentrations in a rat model of T2D without altering body weight. The lower plasma glucose was associated with a 30% reduction in hepatic glucose production resulting from suppression of both gluconeogenesis from pyruvate carboxylase (VPC), explained by a reduction in hepatic acetyl-CoA content, and net hepatic glycogenolysis. In addition, VLCD resulted in reductions in hepatic triglyceride and diacylglycerol content and PKCε translocation, associated with improved hepatic insulin sensitivity. Taken together these data show that there are pleotropic mechanisms by which VLCD reverses hyperglycemia in a rat model of T2D, including reduced DAG-PKCε-induced hepatic insulin resistance, reduced hepatic glycogenolysis, and reduced hepatic acetyl-CoA content, PC flux and gluconeogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Bariatric Surgery: A Systematic Review and Meta-analysis
Buchwald, H., Avidor, Y., Braunwald, E., Jensen, M. D., Pories, W., Fahrbach, K., & Schoelles, K. (2004) · JAMA · doi:10.1001/jama.292.14.1724 · Cited by 6,800
Weight and Type 2 Diabetes after Bariatric Surgery: Systematic Review and Meta-analysis
Buchwald, H., Estok, R., Fahrbach, K., Banel, D., Jensen, M. D., Pories, W. J., Bantle, J. P., & Sledge, I. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.041 · Cited by 2,551 · cited 2×
“Of note, T2D often resolves prior to significant weight loss (Buchwald et al., 2004, 2009; Clements et al., 2004; Schauer et al., 2003), calling into question the mechanism by which bariatric surgery rapidly reduces hyperglycemia.”
Yu, C., Chen, Y., Cline, G. W., Zhang, D., Zong, H., Wang, Y., Bergeron, R., Kim, J. K., Cushman, S. W., Cooney, G. J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200958200 · Cited by 1,561
Self-citationThe pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Samuel, V. T., & Shulman, G. I. (2016) · Journal of Clinical Investigation · doi:10.1172/jci77812 · Cited by 1,484 · cited 2×
“The key question, then, becomes: how does short-term VLCD reverse T2D prior to clinically significant weight loss? Given the key roles of ectopic lipid and increased rates of hepatic glucose production in promoting hepatic insulin resistance and fasting hyperglycemia in T2D (Perry et al., 2014; Samuel and Shulman, 201…”
Self-citationMechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
Samuel, V. T., Liu, Z.-X., Qu, X., Elder, B. D., Bilz, S., Befroy, D., Romanelli, A. J., & Shulman, G. I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313478200 · Cited by 1,322 · cited 1×
“…shown that lipid-induced hepatic insulin resistance is mediated in part through DAG activation of PKC 3resulting in phosphorylation of the insulin receptor tyrosine kinase (IRTK) on threonine 1160, which in turn leads to decreased IRTK activity (Petersen et al., 2016; Samuel et al., 2004, 2007).”
Self-citationBoyle, J. P., Thompson, T. J., Gregg, E. W., Barker, L. E., & Williamson, D. F. (2010) · Population Health Metrics · doi:10.1186/1478-7954-8-29 · Cited by 1,309 · cited 1×
“With type 2 diabetes (T2D) projected to affect one-third of Americans by the year 2050 (Boyle et al., 2010), interventions to reverse diabetes are of particular clinical interest.”
Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus
Schauer, P. R., Burguera, B., Ikramuddin, S., Cottam, D., Gourash, W., Hamad, G., Eid, G. M., Mattar, S., Ramanathan, R., Barinas-Mitchel, E., et al. (2003) · Annals of Surgery · doi:10.1097/01.sla.0000089851.41115.1b · Cited by 1,183
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164 · cited 4×
“…surgery in reversing T2D in humans (Campos et al., 2010; Henry et al., 1985; Isbell et al., 2010; Jackness et al., 2013; Laferrère et al., 2008; Lim et al., 2011; Plum et al., 2011), suggesting that part or all of the metabolic improvements of bariatric surgery may have little to do with the…”
InfluentialEctopic Fat in Insulin Resistance, Dyslipidemia, and Cardiometabolic Disease
Shulman, G. I. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1011035 · Cited by 1,126 · cited 2×
“…hepatic glucose production in promoting hepatic insulin resistance and fasting hyperglycemia in T2D (Perry et al., 2014; Samuel and Shulman, 2016; Shulman, 2014), we undertook a comprehensive study to examine the impact of short-term VLCD on rates of hepatic glucose production and hepatic…”
Self-citationPetersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · cited 1×
“See also Figure S2. hypocaloric (1,200 Kcal) diet resulting in an 10% weight loss over the course of 2 months was sufficient to reverse fasting hyperglycemia, reduce rates of hepatic glucose production, and improve hepatic insulin sensitivity in patients with T2D (Petersen et al., 2005).”
Self-citationPerry, R. J., Camporez, J.-P. G., Kursawe, R., Titchenell, P. M., Zhang, D., Perry, C. J., Jurczak, M. J., Abudukadier, A., Han, M. S., Zhang, X.-M., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.012 · Cited by 719 · cited 2×
“GC/MS was used to measure plasma [2H5]glycerol and [U13C]palmitate enrichment, from which we calculated the rates of lipolysis, correcting for the percent fatty acids that palmitate comprises, as we have described (Perry et al., 2015; Vatner et al., 2015).”
Self-citationLaferrère, B., Teixeira, J., McGinty, J., Tran, H., Egger, J. R., Colarusso, A., Kovack, B., Bawa, B., Koshy, N., Lee, H., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-2851 · Cited by 682 · cited 4×
“…as effective as bariatric surgery in reversing T2D in humans (Campos et al., 2010; Henry et al., 1985; Isbell et al., 2010; Jackness et al., 2013; Laferrère et al., 2008; Lim et al., 2011; Plum et al., 2011), suggesting that part or all of the metabolic improvements of bariatric surgery may…”
InfluentialSamuel, V. T., Liu, Z.-X., Wang, A., Beddow, S. A., Geisler, J. G., Kahn, M., Zhang, X.-M., Monia, B. P., Bhanot, S., & Shulman, G. I. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30400 · Cited by 497 · cited 1×
“…shown that lipid-induced hepatic insulin resistance is mediated in part through DAG activation of PKC 3resulting in phosphorylation of the insulin receptor tyrosine kinase (IRTK) on threonine 1160, which in turn leads to decreased IRTK activity (Petersen et al., 2016; Samuel et al., 2004, 2007).”
Self-citationHENRY, R. R., SCHEAFFER, L., & OLEFSKY, J. M. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-5-917 · Cited by 245
Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids
Vatner, D. F., Majumdar, S. K., Kumashiro, N., Petersen, M. C., Rahimi, Y., Gattu, A. K., Bears, M., Camporez, J.-P. G., Cline, G. W., Jurczak, M. J., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423952112 · Cited by 235 · cited 1×
“GC/MS was used to measure plasma [2H5]glycerol and [U13C]palmitate enrichment, from which we calculated the rates of lipolysis, correcting for the percent fatty acids that palmitate comprises, as we have described (Perry et al., 2015; Vatner et al., 2015).”
Self-citation
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Self-citationThe integrative biology of type 2 diabetes
Roden, M., & Shulman, G. I. (2019) · Nature · doi:10.1038/s41586-019-1797-8 · Cited by 1,167
Self-citationTaylor, R., Al-Mrabeh, A., Zhyzhneuskaya, S., Peters, C., Barnes, A. C., Aribisala, B. S., Hollingsworth, K. G., Mathers, J. C., Sattar, N., & Lean, M. E. J. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.07.003 · Cited by 450
Understanding the mechanisms of reversal of type 2 diabetes
Taylor, R., Al-Mrabeh, A., & Sattar, N. (2019) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(19)30076-2 · Cited by 299
Current treatments for obesity
Ruban, A., Stoenchev, K., Ashrafian, H., & Teare, J. (2019) · Clinical Medicine · doi:10.7861/clinmedicine.19-3-205 · Cited by 266
Metadata
- Authors
- Perry, R. J., Peng, L., Cline, G. W., Wang, Y., Rabin-Court, A., Song, J. D., Zhang, D., Zhang, X.-M., Nozaki, Y., Dufour, S., Petersen, K. F., & Shulman, G. I.
- Venue
- Cell Metabolism
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 27
- Issue
- 1
- Pages
- 210-217.e3
- ISSN
- 1550-4131 (ISSN-L)
- OpenAlex
- W2767364777
- Cited by
- 88
- References
- 16
- FWCI
- 4.46
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.